Compare BABA & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BABA | MRK |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.4B | 317.8B |
| IPO Year | 2014 | 1997 |
| Metric | BABA | MRK |
|---|---|---|
| Price | $110.44 | $145.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 40 | 27 |
| Target Price | ★ $185.87 | $158.04 |
| AVG Volume (30 Days) | ★ 6.2M | 5.7M |
| Earning Date | 11-24-2026 | 10-29-2026 |
| Dividend Yield | 0.94% | ★ 2.33% |
| EPS Growth | N/A | ★ 8.01 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $65,011,000,000.00 |
| Revenue This Year | $9.25 | $3.19 |
| Revenue Next Year | $13.02 | $4.27 |
| P/E Ratio | $21.20 | ★ N/A |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | $91.99 | $82.01 |
| 52 Week High | $182.50 | $157.00 |
| Indicator | BABA | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 51.47 |
| Support Level | $107.20 | $142.32 |
| Resistance Level | $121.13 | $153.19 |
| Average True Range (ATR) | 2.04 | 3.37 |
| MACD | 0.45 | -0.44 |
| Stochastic Oscillator | 80.21 | 51.25 |
Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China retail e-commerce platform is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China wholesale e-commerce, international retail and wholesale e-commerce, local consumer services, travel services, cloud computing, digital media and entertainment, Cainiao logistics services, and other businesses.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).